Efficacy, Safety, and Immunogenicity of Insulin Aspart Biosimilar SAR341402 Compared with Originator Insulin Aspart in Adults with Diabetes (GEMELLI 1): A Subgroup Analysis by Prior Type of Mealtime Insulin

Shah, VN; Franek, E; Wernicke-Panten, K; Pierre, S; Mukherjee, B; Sadeharju, K

Shah, VN (corresponding author), Univ Colorado Anschutz Med Campus, Barbara Davis Ctr Diabet, Aurora, CO 80045 USA.

DIABETES THERAPY, 2021; 12 (2): 557

Abstract

Introduction: The biosimilar SAR341402 insulin aspart (SAR-Asp) was compared to its originator NovoLog (R)/NovoRapid (R) insulin aspart (NN-Asp) in te......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索